It is the foundation of how we develop, manufacture, and deliver regenerative biomaterials. Recognized standards establish the baseline; our internal expectations go further.
QUALITY & COMPLIANCE
SigmaGraft is committed to rigorous global standards that support product safety, quality, and traceability.
ISO 13485 aligned
Internationally recognized
Controlled throughout
Our highest priority
It is the foundation of how we develop, manufacture, and deliver regenerative biomaterials. Recognized standards establish the baseline; our internal expectations go further.
Patient safety and product integrity guide our decisions at every stage.
Documented systems support consistency, traceability, and reliable performance.
We continually evaluate and strengthen our processes, training, and quality culture.
It is the foundation of how we develop, manufacture, and deliver regenerative biomaterials. Recognized standards establish the baseline; our internal expectations go further.
We follow internationally recognized quality management system requirements for medical device manufacturing.
Our quality system supports the regulatory requirements of the United States, Canada, Brazil, Japan, and Australia.
We follow tissue banking standards for the responsible processing, storage, and distribution of donated human tissue.
Testing and product characterization are performed in accordance with applicable ASTM, USP, ISO, and other recognized standards.
Regulatory Compliance
We maintain controls that support product safety, traceability, and compliance across the markets we serve.
We follow current good manufacturing practices to help ensure medical devices distributed in the United States are consistently manufactured for safety and performance throughout their life cycle.
Our donor screening, processing, manufacturing, storage, and distribution practices are designed to reduce the risk of disease transmission and protect product safety.
Products reaching more than 30 countries are supported by compliance with applicable local and national requirements across the European Union, South Korea, Mexico, Colombia, Saudi Arabia, and other markets.
We comply with applicable local, state, and federal requirements related to employee safety, environmental responsibility, and responsible operations.
Beyond Compliance
Compliance defines what is required. Our responsibility is to continually strengthen the systems, processes, and culture that protect every patient touched by our products.
We collaborate with healthcare professionals, distributors, and industry partners who share our commitment to quality.
JOB INQUIRY
Submit your inquiry to info@sigmagraft.com about a job opportunity or submit your resume.
Elcin Chang is the Executive Vice President of SigmaGraft Biomaterials, where he oversees the research and development of next-generation biomaterials, the manufacture of high-quality medical devices, and the company’s private-label business segment.
Elcin Chang joined SigmaGraft in 2019, initially working in legal and regulatory affairs before becoming involved in nearly every aspect of the business, from research and development to manufacturing. He graduated from the University of San Diego with a degree in political science and joined the U.S. Army Reserve after college. He later earned both a law degree and an M.B.A. from the University of Maryland.
Outside of work, Elcin enjoys traveling and playing sports. He is deeply committed to his work, family, church, and community.